>

WEBINARS

RSS
>

MEETINGS / EVENTS

RSS
>

FDA MEDWATCH ALERTS

RSS

January 12, 2012

Respironics, Inc. Trilogy 100 Ventilators: Class I Recall - Device May Stop Delivering Therapy to Patient

Summary:

FDA notified health care professionals of the Class 1 recall of this product due to a manufacturing issue can stop delivering therapy to the patient. Part of the blower that circulates air and other gases through the ventilator may move out of position and cause the device to alarm.  Failure to respond could result in the potential for harm or death of a ventilator-dependent patient.

January 12, 2012

Bedford Laboratories Vecuronium Bromide And Polymyxin B For Injection USP For Injection: Recall - Glass Particles

Summary:

Bedford Laboratories issued guidance on the nationwide voluntary product recalls originally issued on August 2, 2011. The recalls were initiated after the discovery of a visible glass particle in a limited number of vials within the lots listed.

January 09, 2012

Endo Pharmaceuticals Opiate Products by Novartis Consumer Health: Public Health Advisory - Potential Safety Risk

Summary:

FDA is advising health care professionals and patients of a potential problem with opiate products manufactured and packaged for Endo Pharmaceuticals by Novartis Consumer Health at its Lincoln, Nebraska manufacturing site.

>

ASA FEATURED PRODUCT

Self-Education and Evaluation (SEE) Program

SKU: 30701-12CE

... Read more »

Single Copies, Member Price: $300

Bipartisan Senate letter urges review of Medicare payments for anesthesiology

Wednesday, August 25, 2010

ASA applauds the recent Senate letter dated August 23, 2010, to HHS Secretary Kathleen Sebelius urging a review of Medicare payments for anesthesia services as potentially undervalued or misvalued. In total, 16 U.S. Senators signed the letter.

ASA is grateful to its members for bringing this issue to the attention of the U.S. Senate and is pleased to have strong support from these 16 Senators.

For years anesthesiology has suffered from a Medicare payment disparity. Recent analysis by the Government Accountability Office (GAO), as confirmed by ASA’s own survey data, indicates that Medicare rates are 33 percent of what commercial insurers pay for the same service. Meanwhile, most other physician specialties receive at least 80 percent of commercial rates from Medicare. This significant gap warrants further examination and continued action.

Please use the following links for more information:

Senate sign-on letter to Secretary Sebelius 

Congressional sign-on letter to Secretary Sebelius 

Outpatient Surgery Magazine, Lawmakers Ask HHS to Review Medicare Rates for Anesthesia Services

Becker’s ASC Review, Senate Letter to HHS Secretary Urges Review of Anesthesia Medicare Payments

« Back to Washington Alerts